COVID-19: Information on ASPIRA LABS Operations

Click to Learn More
  • Home
  • ASPIRA GenetiX Technology Transfer

ASPIRA GenetiX Technology Transfer

Introducing Technology Transfer for Genetic Testing (AGTT)


AGTT is a cloud-based technology transfer solution that provides an end-to-end platform for clinical laboratories to offer hereditary cancer and carrier screening genetic testing in house.

Advantages of Outsourcing with AGTT


AGTT allows genetic tests to be run at scale with significantly reduced cost, time, and labor.

Developed by a team of experts, AGTT is a first in its class, custom-built technology which leverages a novel AI-based bioinformatics pipeline. This ground breaking technology is customized to deliver simplified workflows, reduced overhead and provides an added revenue stream for your laboratory.

ASPIRA's End to End Solution


AGTT ASPIRA's End to End Solution Chart Details

Customized & Simplified Solution


Our custom bioinformatics pipeline allows for a single NGS assay despite the industrywide difficulties in variant calling within paralogous genes (i.e. HBA1 and HBA2) and regions of high homology (i.e. SMN1 and SMN2). This reduces the need for orthogonal tests that are commonly implemented to interrogate these difficult regions. ASPIRA Women’s Health can also provide custom solutions to further elucidate paralog regions based on specific customer needs.

AGTT Infographics of Statistics

Aspira Women’s Health
Development Support


  • White Glove Services
  • Validation Assistance
  • Software
  • Applications
  • Team Expertise

AGTT Workflow


ASPIRA Women's Health Development Support

Questions? Let's set up a time to chat!